RxDoctor Payments Data

Krishna Mutgi

Dermatology · Toledo, OHNPI 1720346133

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,119 of the $108,308 with a category attached, or 81.4%. Sanofi accounts for 60.5% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $64,227, more than ten times the $291 reported in 2019. Among dermatology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$108,308in general payments, 2019–2025

Across 689 payments — averaging $157.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$65K
  • Galderma Laboratories, L.p.$26K
  • Chiesi USA, Inc.$6K
  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Johnson & Johnson$767
  • plus $6K from 29 others

What the payments were for

  • Speaking & faculty fees$88,11981%
  • Travel & lodging$7,4047%
  • Food & beverage$12,14111%
  • Education$6441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$108,308 in reported general payments places this provider in the 95th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio

Medicare billing

Part B allowed, 2024
$394,729
Medicare patients
561
Services billed
8,679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab58$215,054
Cosentyx Unoready PenSecukinumab11$153,095
Dupixent SyringeDupilumab16$57,744
Clobetasol Propionate104$4,750
Fluorouracil38$2,999
Ciclopirox29$1,051
Doxycycline Hyclate46$1,026
Cephalexin53$948
Triamcinolone Acetonide84$901
Fluocinonide20$785
CiclopiroxCiclopirox Olamine53$749
Mupirocin116$618
Metronidazole14$598
Hydrocortisone67$418
Minocycline Hcl16$408

Paid to pharmacies, not to this prescriber.

Other dermatology in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →